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Abstract 
Ischaemia-reperfusion (I/R) injury remains the primary contributor to delayed graft function in 
kidney transplantation. The beneficial application of manganese superoxide dismutase (sod), 
delivered by a BacMam vector, against renal I/R injury has not been evaluated previously. 
Therefore, in this study we overexpressed sod-2 in proximal tubular epithelial (HK-2) cells 
and porcine kidney organs during simulated renal I/R injury. 
Incubation of HK-2 cells with antimycin A and 2-deoxyglucose resulted in a significant 
decrease in intracellular ATP levels; following reperfusion, ATP levels significantly increased 
over time in cells overexpressing sod-2. In addition, lactate dehydrogenase (LDH) release 
declined over 72 h in BacMam-transduced injured cells. Ex vivo delivery of sod-2 
significantly increased ATP levels in organs after 24 h of cold perfusion. 
In vitro and ex vivo results suggested that BacMam transduction successfully delivered sod-
2, which reduced injury associated with I/R, by improving ATP cell content and decreasing 
LDH release with a subsequent increase in kidney tissue viability. These data provide further 
evidence for the potential application of BacMam as a gene delivery system for attenuating 
injury after cold preservation. 
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Introduction 
Ischemia followed by reperfusion (I/R) is a pivotal mechanism of organ injury in various 
medical conditions1. Clinically, I/R injury is associated with delayed graft function, graft 
rejection, chronic rejection and chronic graft dysfunction1. I/R injury is characterized by 
restriction of blood supply to an organ followed by restoration of blood flow and re-
oxygenation. This can results in a severe hypoxic state (prolonged insufficient flow of 
nutrients and oxygen to the organ) activating cell death programs1.Renal hypoxia injury has 
been shown to be related to a number of cellular biochemical, physiological and 
morphological alterations, including increased reactive oxygen species (ROS). In particular 
hypoxia leads to a severe depletion of intracellular ATP that causes the activation of 
apoptotic pathways4,5. 
I/R injury still remains a major cause of acute kidney injury (AKI) resulting in high levels of 
morbidity and mortality2 and is a major determinant of graft survival in kidney 
transplantation3. Two types of ischaemia may occur during renal transplantation, warm and 
cold ischaemia. Warm ischaemia is further divided into donor warm ischaemia (either after 
circulatory death or after brain death) and recipient warm ischaemia. Cold ischaemia occurs 
when kidneys collected from living donors are directly placed in cold preservation solution. 
The work described in this study sought to examine the possibility of reducing injury 
associated with cold preservation. 
Emerging strategies tried to prevent renal I/R injury by preserving ATP levels in an attempt 
to improve short- and long-term outcomes following kidney transplantation6,7,8,9. In vitro 
models are generally used to study molecular mechanisms, specific pathways involved in 
cellular damage or death caused by I/R injury events; they provide evidence for further in 
vivo analysis. However, as cell-based experimental models mimic only some of the features 
of tissue ischaemia and I/R injury, they cannot reproduce the in vivo tissue environment 
completely10. The major areas of in vitro I/R injury investigation have included 
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overexpression of protective genes, enhancing enzyme activity and suppressing the 
expression of genes that activate the cell death pathway. Because low blood supply during 
I/R injury leads to the deprival of ATP concentration, most cell-based models of I/R have 
focussed on inhibiting the production or synthesis of ATP through chemical11, enzymatic12 or 
anaerobic chamber13 approaches14. In the present study, we used a chemical approach to 
induce I/R injury in an immortalized proximal tubule epithelial cell line (HK-2) from normal 
adult human kidney. 
Mitochondria are the main cellular sites of radical oxygen species production; consequently, 
they represent an early target of oxygen injury via enhanced production of ROS, followed by 
mitochondrial dysfunction15. Manganese superoxide dismutase (SOD-2) is the major 
antioxidant in the mitochondria; it localizes in the mitochondrial matrix16 and exists as a 
homotetramer containing one Mn (Manganese) atom per subunit8. Its main function is to 
catalyse the dismutation of the superoxide anion (O2•-) producing hydrogen peroxide (H2O2)8.
Studies, using a rodent model of renal I/R injury, showed endogenous SOD-2 was rapidly 
inactivated at early times during renal transplantation; suggesting that loss of SOD-2 activity 
may have played an important role in inducing further injury17,18,19, e.g. SOD-2 deficiency in 
mice leads to prenatal lethality15. Furthermore, a number of reports have shown that high 
levels of SOD-2 play a key role in attenuating injury or death under conditions of enhanced 
oxidative stress21,22,23. 
To date, more than 70% of clinical trials and gene therapy studies have been carried out 
using mammalian virus vectors such as adenovirus24,25. BacMam vectors (baculovirus-based 
vectors for expression in mammalian cells) provide an attractive alternative allowing scalable 
virus production26. 
A number of studies have reported that the mode and kinetics of BacMam entry into 
mammalian cells is identical to that found in insect cells27,28. Baculovirus enters insect cells 
by receptor-mediated endocytosis, followed by pH-dependent fusion of the envelope with the 
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endosome27,28. BacMam vectors also enter mammalian cells via endocytosis and are 
released into the cytoplasm by acid-induced fusion of the envelope with the endosomal 
membrane. Studies have suggested that the rod shaped nucleocapsid, containing the virus 
genome, is then transported into the nucleus through a nuclear pore.29. The prototype 
baculovirus used for BacMam studies is Autographa californica multiple 
nucleopolyhedrovirus (AcMNPV)22. High-levels of expression have been observed in 
transduced vertebrate cells and these vectors have low cytotoxicity, high insert size capacity 
and a relatively low immune-response profile compared to mammalian virus-vectors 
23,26,30,31,32,33
. A number of studies have reported that baculovirus stimulates an immune-
response in mammalian cells. It was demonstrated that baculovirus possess an adjuvant 
activity that promotes humoral and cellular immune responses against co-administered 
antigens, maturation of dendritic cells (DCs), and production of pro-inflammatory 
cytokines34,35,36,37,38. Indeed, our previous studies have suggested that BacMam can regulate 
the cellular immune-response by up-regulating a number of cytokines and other immune-
response genes after in vitro transduction into HEK293 cells. However, it should be noted 
that no apparent cellular injury or reduction in cell viability was observed after in vitro and ex 
vivo solid organ transduction39. Therefore, adaptive and innate immunity should be taken 
into consideration when designing the BacMam gene delivery approach. 
The purpose of this study was to investigate BacMam as a novel gene delivery vector for the 
prevention of acute cell damage caused by ischemia. In particular, experiments were 
designed to examine the potential application of BacMam in delivering sod-2 using an in vitro 
model that closely mimicked renal I/R injury. We also evaluated whether ex vivo BacMam 
delivery of sod-2 in porcine kidneys might improve I/R induced renal injury during cold 
preservation. 
Page 5 of 30
6 
Material and Methods 
Materials 
Antimycin A and 2-deoxy-D-glucose (2-deoxyglucose) were purchased from Sigma-Aldrich 
Co Ltd. Phosphate buffer saline (PBS) was supplied by GIBCO (Life Technologies Ltd). 
Foetal bovine serum (FBS) was supplied by Lonza Group Ltd and heat inactivated at 56°C 
for 30 min. 
Cell Culture 
Insect cells were maintained at 28°C in Erlermeyer flasks (Corning) and glass Spinner 
flasks, respectively. Sf-9 cells were passaged before reaching their stationary phase using 
Sf9-S2 medium (PAA Laboratories Ltd); Sf-21 cells were maintained in TC100 (GIBCO, Life 
Technologies Ltd) supplemented with 10% FBS. HK-2 cells were purchased from American 
Type Culture Collection (ATCC) and cultured in Keratinocyte Serum Free Medium (KSFM; 
GIBCO, Life Technologies Ltd.) supplemented with 2% antibiotics (100 IU/ml penicillin, 100 
µg/ml streptomycin) at 37°C 5% CO2. 
Plasmid construction and generation of BacMam vector 
The pCI-neo plasmid, carrying the human cytomegalovirus immediate-early enhancer (CMV-
IE) promoter, was kindly provided by Prof Bermudez-Diaz (Oxford Brookes University, 
Oxford, UK). The pMA_SOD-2 plasmid was obtained from GeneArt® (Life Technologies 
Ltd); the sod-2 gene was synthesized based on the sequence of GenBank (accession 
number: Y00985). The baculovirus-based pBAC-1 plasmid was purchased from Novagen 
(EMD Biosciences, Inc). 
To generate a pBAC-1 plasmid containing a CMV-IE promoter, the CMV-IE region was 
excised from pCI-neo with restriction endonucleases BglII and XhoI. The CMV-IE promoter 
fragment was then ligated into the linearized pBAC-1 DNA, generating a pBAC-1_CMV 
transfer plasmid. Polymerase chain reaction (PCR) primers were designed for sod-2; (1) 
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forward primer 5’ AATTGAATTCGCACCATGTTGAGCCGGG 3’ and (2) reverse primer 3’ 
GTACCGAACGTTTTTCATTAGATCTTAAT 5’. The EcoRI (GAATTC) restriction site was 
added to the 5′ end of forward primer, while the XbaI (AGATCT) and terminator codon (TAA) 
were added to the 5′ end of the reverse primer. The sod-2 fragment was amplified from the 
pMA_SOD-2 plasmid by PCR using forward and reverse primers. The amplified sod-2 
fragment and pBAC-1_CMV plasmid were digested simultaneously with EcoRI and XbaI and 
then ligated to create pBAC-1_SOD-2. 
BacMam viruses were generated by homologous recombination between flashBAC 
ULTRA™ DNA (Oxford Expression Technologies Ltd) and pBAC-1_SOD-2 plasmid DNA, 
according to the manufacturer’s instructions. The virus containing supernatant, 
AcCMV_SOD-2, was then harvested 5 days post-transfection and stored at 4°C. FBS (5% 
v/v) was added to the inoculum to improve stability during storage. High titre BacMam stock 
was obtained following further amplification of the viral stock in Sf-9 cells. AcCMV_SOD-2 
virus was titrated by plaque assay40. 
Porcine kidney 
Experiments were performed in accordance with the principles of the Oxford Brookes 
University Ethics Committee. Porcine kidneys were obtained from a local abattoir. Organs 
were collected within 10 min after slaughter (22 week old large white pigs) and ﬂushed in situ 
with soltran kidney perfusion fluid (0.86% w/v potassium citrate, 0.82% w/v sodium citrate, 
3.38% w/v mannitol and 1% w/v magnesium sulphate; Baxter). Kidneys were immediately 
transported in a biohazard bag, on ice (approximately 45 min), to the laboratory for analysis. 
In vitro viral delivery 
HK-2 cells were seeded at a concentration of 0.3x106 cells/ml and incubated overnight at 
37°C in 5% CO2. The following day, cells were transduced with BacMam viruses at an 
multiplicity of infection (MOI) of 150 pfu/cell and incubated at 37°C for 1 h in 5% CO2. The 
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virus inoculum was then replaced with growth culture medium and cells were returned to 
37°C in 5% CO2 for the required time. 
In vitro I/R injury model 
HK-2 cells were incubated in a phosphate saline buffer (PBS) containing 10 µM antimycin A 
(a complex III inhibitor of mitochondrial electron transport) and 10 mM 2-deoxyglucose (a 
nonmetabolizable isomer of L-glucose and a glycolysis inhibitor) for 60 min to induce in vitro 
ischemia injury41. Reperfusion was achieved in HK-2 cells by washing with PBS and then 
culturing in complete growth medium. 
Ex vivo viral delivery 
Flushed kidney organs were cannulated and perfused through the renal artery with 200 ml of 
cold Belzer UW solution (Bridge to Life (Europe) Ltd), with or without BacMam. BacMam was 
concentrated using low speed-centrifugation and pellet dissolved in a physiological saline 
solution. During transduction, the 200 ml Belzer UW solution was collected and recirculated 
using a low-speed peristaltic pump (10 rpm; Watson Marlow 505 S, Gemini BV). Kidneys 
were transduced for 24 h. Tissue samples were collected using a 10 ml syringe at 0, 4 and 
24 h post-transduction (hpt) and cells were immediately dissociated using collagenase 
(Sigma-Aldrich Co. Ltd). 
Measurement of cellular injury (ATP assay) 
Intracellular ATP levels were measured using a CellTitre-Glo® Luminescent Cell Viability 
Assay (Promega). Initially, the assay buffer and the lyophilized substrate were mixed 
together and left to equilibrate at room temperature for 20 min. During the equilibration time, 
cells to be analysed were harvested by centrifugation and re-suspended in 100 µl of 1X 
PBS. Subsequently, 100 µl of the assay reagent were added into each tube and then mixed 
to release intracellular ATP into solution. After 5 min incubation, luminescence was read on 
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a GloMax® 20/20 Luminometer (Promega). Data were normalized against the live cell 
number obtained using a trypan blue exclusion assay. 
Measurement of cytotoxicity (LDH assay) 
Cell viability was assessed by measuring the release of LDH into the culture media using 
CytoTox-ONE Homogeneous Membrane Integrity Assay (Promega). The CytoTox-ONE™ 
assay was carried out according to the manufactures guidelines. Briefly, mammalian cells to 
be evaluated were seeded into individual wells of a 96 well plate (Corning), treated with the 
appropriate chemical and incubated at 37°C for the required time. 2 µl of lysis solution 
(supplied by the manufacturer) were added to the untreated cells for maximal LDH release. 
Untreated cells were used as negative control and a blank well served as a vehicle control. 
The cells were removed from 37°C and equilibrated at 22°C for 20 min. CytoTox-ONE 
reagent was then added in an equal volume to the cell culture medium present in each well 
and shaken gently for 30 sec. Cells were incubated at 22°C for 10 min and the reaction was 
stopped by adding 50 µl of stopping solution to each well. Fluorescence was recorded at an 
excitation wavelength of 560nm and an emission wavelength of 590nm using an Infinite® 
200pro microplate reader (Tecan Group Ltd). Cytotoxicity values were obtained using the 
following calculation: 
 
Western blot analysis 
Proteins separated on 12% SDS-PAGE gels were transferred onto a nitrocellulose 
membrane (GE Healthcare, UK) and analysed by western blot. Protein gels were incubated 
in transfer buffer (48 mM Tris, 39 mM glycine, 20% methanol and 1.3 mM SDS) for 5 mins 
together with the nitrocellulose membrane and filter papers. Following the transfer, 
membranes were incubated in 5% powdered milk dissolved in PBST (1X PBS containing 
 (Experimental – Culture Medium Background) 
Cytotoxicity (%) =  X100 
 (Maximum LDH Release – Culture Medium Background) 
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0.1% (v/v) of Tween20) and agitated at room temperature for 1 h to prevent non-specific 
binding. Subsequently, membranes were treated with SOD-2 primary antibody for 60 min. 
Membranes were washed 3X with PBST and incubated with a secondary antibody 
conjugated with alkaline phosphatase for 60 min. To remove any background, membranes 
were washed 3X with PBST. Bound proteins were visualized using alkaline phosphatase 
buffer (100 mM Tris-HCl (pH=9.5), 100 mM NaCl and 5 mM MgCl) containing 66 µl of Nitro 
Blue tetrazolium (NBT) and 33 µl of 5-Bromo-4-Chloro-3'-Indolyphosphate p-Toluidine 
(BCIP). The reaction was stopped by washing the membrane with in dH2O (distilled water) 
and any excess liquid was removed using filter paper. Band densitometry was carried out 
using GelQuantNET software (BiochemLabSolutions). 
Confocal microscopy 
Deparaffinised and hydrated kidney sections were permeabilised with 1X PBS containing 
0.1% (v/v) Triton X-100. Tissue sections were blocked in 1X PBS-BSA prior to being 
incubated in the appropriate primary antibodies for 60 min at room temperature. Slides were 
washed three times in 1X PBS and incubated with the indicated secondary antibodies for 60 
min at room temperature. Finally, any unbound antibody was removed using PBS and 
sections were mounted with Vectashield (Vector Laboratories) a mounting media containing 
the nuclear label 4',6-diamidino-2-phenylindole (DAPI). A clear nail-varnish was used to seal 
the mounted samples before being stored in the dark at 4°C. 
Confocal microscopy was performed on fixed tissue sections using a Zeiss LSM 510 Meta 
confocal system using X63 oil immersion lens. Multitrack analysis was carried out in order to 
analyse green fluorescence (488nm excitation, band pass filter 505-530nm), red and blue 
(DAPI) fluorescence (543nm excitation, long pass filter 560nm for red, and 405 excitation, 
band pass filter 420-480nm for blue). Image data were analysed using LSM Image browser 
software. 
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Statistical analysis 
All data were analysed using GraphPad Prism version 5 for Windows (GraphPad Software 
Inc., USA) with results displayed as mean ± SEM. Statistical analysis was performed using 
both one- and two-way ANOVA with a Bonferroni post-test that compared replicative mean 
values, unless otherwise stated. A p-value of <0.05 was considered statistically significant. 
Results 
BacMam-mediated sod-2 expression in HK-2 cells 
Initial studies were performed to evaluate the relative BacMam transduction efficiency and 
the optimal transgene expression levels in human proximal tubule cells. HK-2 cells were 
transduced using different MOI with AcCMV_SOD-2 BacMam over a period of 96 h (hour). 
Results indicated that the viral dose played an important role in efficient transduction of HK-2 
cells; MOI 150 resulted in minimal cytotoxicity and therefore was chosen as optimal for HK-2 
cells (data not shown). Preliminary experiments showed that SOD-2 gradually increased 
from 0 h to 96 h following transduction with BacMam, as confirmed by western blot analysis 
(Figure 1). This was further confirmed by densitometry analysis, which indicated that SOD-2 
expression increased from less than 1% to 11% within 24 h and subsequently to 23%, 32% 
and 34%, at 48, 72 and 96 hpt (hour post-transduction), respectively (Figure 1). Because 
SOD-2 was optimally expressed between 72 and 96 h post-transduction, the 72 hpt time-
point was chosen to assess the effect of BacMam-mediated gene delivery in an in vitro I/R 
injury model in HK-2 cells. 
Antimycin A and 2-Deoxyglucose/ATP-depletion injury in HK-2 cells 
To investigate the effects of I/R on renal cell injury, HK-2 cells were treated with antimycin A 
(10 µM) and 2-deoxyglucose (10 mM) to mimic the in vivo I/R response. As shown in Figure 
2, exposure of HK-2 cells to chemicals caused an approximately two-fold decrease in 
intracellular ATP levels within 15 min of their addition compared to non-treated cells (filled 
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squares vs. filled circles). This decrease in ATP levels was further induced in a time-
dependent manner; the cellular ATP content decreased by four-, nine- and six-fold following 
30, 45 and 60 min of chemical treatment, respectively (p<0.001, N=3). 
Protective effect of sod-2 following ATP depletion-recovery in HK-2 cells 
To investigate whether BacMam-delivered sod-2 would protect against renal injury, HK-2 
cells were transduced for 72 h with AcCMV_SOD-2 followed by exposure to antimycin A and 
2-deoxyglucose41. As shown in Figure 3, HK-2 cells transduced with AcCMV_SOD-2, 72 h
prior to I/R injury, exhibited a time-dependent increase in their intracellular ATP content 
(filled triangles) compared to cells transduced with an empty BacMam containing no gene, 
(AcCMV_NULL; filled square). BacMam-mediated sod-2 delivery showed an improved 
recovery of the cellular ATP content in the first 24 h of reperfusion (60% increases) 
compared to AcCMV_NULL transduced/injured cells (40%). ATP levels were significantly 
increased at 48 and 72 h after reperfusion in AcCMV_SOD-2 transduced/injured cells when 
compared to control cells and AcCMV_NULL transduced/injured cells (p<0.001, n=3). 
Cytotoxicity was measured by the amount of LDH released from the cells into the media 
following the ATP depletion-recovery period. As shown in Figure 4, following 60 min of 
ischemia and 5 min of reperfusion, a significant increase in LDH release was detected 
(p<0.05, n=3) in AcCMV_NULL and AcCMV_SOD-2 transduced/injured cells (filled squares 
and triangles, respectively) compared to control cells (non-injured; filled circles). Prolonging 
the reperfusion phase, we observed that SOD-2 overexpression in HK-2 cells resulted in 
80%, 75% and 70% reduction in LDH release following 24, 48 and 72 h of reperfusion, 
respectively, compared to AcCMV_NULL transduced/injured cells (Figure 4). However, this 
time-dependent reduction in LDH release was only partial, since cytotoxicity in 
AcCMV_SOD-2 transduced injured cells, at 72 h after reperfusion, was still significantly 
higher compared to control cells (non-injured). 
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Effects of ex vivo BacMam-mediated sod-2 delivery against I/R-induced renal injury 
during cold preservation 
Initially, we demonstrated the feasibility of ex vivo BacMam gene transfer into a whole 
porcine kidney during cold preservation using a fluorescent marker. Immuno-detection 
showed Enhanced Green Fluorescent Protein (EGFP) specific staining in AcCMV_EGFP 
transduced kidney tissues but not in control kidneys (Figure 5). 
Six fresh porcine kidneys (three left and three right) were obtained from a local abattoir, 
flushed in situ and then placed in a plastic bag surrounded by ice packs and immediately 
transported to the laboratory for analysis. Kidneys were divided into three experimental 
groups: group I (perfused control kidneys, no-virus), group II (AcCMV_EGFP transduced and 
perfused kidneys) and group III (AcCMV_SOD-2 transduced and perfused kidneys): each 
group contained a paired kidney (one left and one right) excised from the same pig. During 
the 24 h period of perfusion/transduction, triplicate tissue samples were collected from the 
left kidneys of each experimental group, weighed and enzymatically dissociated into single 
cells, using collagenase, for intracellular ATP analysis. As shown in Figure 6, ATP levels 
detected 0 h post-perfusion (hpp) in AcCMV_EGFP and AcCMV_SOD-2 transduced kidneys 
(0.4 and 0.3 nM, respectively) were not significantly different (p>0.05, n=3) compared to ATP 
concentrations detected in the non-transduced control group (0.3 nM). Significantly 
increased ATP levels were detected at 4 hpp in AcCMV_SOD-2 perfused/transduced kidney 
(0.7 nM) compared to those detected in non-treated transduced kidney and AcCMV_EGFP 
transduced/perfused kidney, 0.25 and 0.24 nM (p<0.001, n=3), respectively; ATP levels in 
AcCMV_EGFP transduced kidney were not significantly different (p>0.05, n=3) from the non-
transduced control group (Figure 6, light grey bars vs. black bars). 
Furthermore, a marked and significant increase (p<0.001, n=3) in intracellular ATP 
concentration was detected at 24 hpp in AcCMV_SOD-2 transduced/perfused kidney tissue 
(0.8 nM) compared to ATP levels observed in the experimental control group 0.5 nM (Figure 
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6, dark grey bars vs. black bars). In contrast, the intracellular ATP levels significantly 
decreased (p<0.001, n=3) in AcCMV_EGFP transduced/perfused kidney (0.2 nM) when 
compared to both AcCMV_SOD-2 and control experimental groups (Figure 6, light grey bars 
vs. dark grey bars). 
Discussion 
In order to study renal I/R injury, we initially performed in vitro experiments using proximal 
tubular cells. Western blot analysis confirmed BacMam transduction of HK-2 cells and 
demonstrated increasing SOD-2 expression over-time, as indicated by densitometry analysis 
(Figure 1). Although, a number of studies have described the delivery of sod-2 by viral 
vectors, mainly using adenovirus42,43, this is the first study demonstrating the feasibility of 
BacMam to deliver sod-2 to HK-2 cells. 
The in vitro I/R injury model used in this study reproduced a number of key hallmark features 
of ischemia such as intracellular ATP depletion as well as reduction in tissue oxygen and 
glucose contents44. Previous studies demonstrated that the combination of antimycin A and 
2-deoxyglucose produced 90% ATP depletion in HK-2 cells41,44,45. This is consistent with our
findings where the combination of antimycin A and 2-deoxyglucose induced cellular injury; 
indeed, the intracellular ATP levels were significantly reduced within 30 min of treatment 
(Figure 2). Likewise, previous studies have demonstrated that the ATP/glucose depletion 
model of anoxia/ ischemia Belzer UW dramatically depleted intracellular ATP levels to 1-4% 
of control cells41,46, as observed in our experiments. Kevin et al.47 demonstrated that 
treatment of Madin-Darby canine kidney (MDCK) cells with 10 µM antimycin A dissolved in a 
Dulbecco’s phosphate-buffered saline (DPBS glucose-free), caused a rapid decrease in the 
intracellular level of ATP; by 2 h levels were below the limit of detection and essentially zero 
after 5 h. 
Having established and validated a cell culture model of renal injury, we next determined 
whether I/R injury could be either reduced or prevented in HK-2 cells by the delivery of sod-2 
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via BacMam. SOD-2 transduced-injured cells showed a trend of increasing intracellular ATP 
levels over-time (20% to 140%), with ATP recovery observed at 72 h, compared to 
AcCMV_NULL transduced/injured cells (19% to 86%; Figure 3). Since the intracellular ATP 
content is essential for maintaining normal cellular functions as well as cellular integrity, it 
should be noted that any increase, even small, in ATP content during I/R injury might 
contribute to long-term cellular recovery. Although ATP recovery was observed at 72 h post-
reperfusion in AcCMV_SOD-2 transduced/injured cells, the increase in ATP levels, observed 
between 6 and 48 h post-reperfusion, also exerted a protective effect against I/R injury. 
These observations were in agreement with published models of renal I/R injury in cells 
overexpressing SOD-235. Cruthirds et al.48 demonstrated that after stable transfection, 
normal renal kidney (NRK) cells producing recombinant SOD-2 were protected against I/R 
injury induced by ATP depletion. Koo et al.43 generated a stable alveolar epithelial cell line 
overexpressing SOD-2; they demonstrated that the overexpression of SOD-2 signiﬁcantly 
protected cells within the ﬁrst 48 h of hyperoxia exposure and signiﬁcantly increased the 
number of viable cells. 
Exposure of transduced HK-2 cells to I/R injury (0 hpr) resulted in an increased release of 
LDH compared to control cells (Figure 4). However, time-course analysis of I/R-induced LDH 
release in AcCMV_SOD-2 injured HK-2 cells showed a decrease in LDH levels at 24, 48 and 
72 hpr compared to AcCMV_NULL transduced/injured cells, which remained higher during 
the 72 h of reperfusion (Figure 4). These findings were consistent with the ATP data (Figure 
3). 
A number of reports have demonstrated that the primary cause of ischemia in the kidneys is 
due to clamping of the renal arteries, which may occur during the surgical procedure of renal 
transplantation49. In particular, strategies for organ preservation are fundamentally based on 
the prevention or suppression of the metabolic changes that occur during I/R injury49. 
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We observed EGFP expression following ex vivo transduction into porcine kidneys (Figure 5, 
panel A2)50 and to our knowledge, this is the first evidence of ex vivo sod-2 delivery in 
kidneys using BacMam. We also tested whether augmentation of sod-2 might improve I/R 
induced renal injury during cold preservation. A progressive and significant increase in ATP 
concentration was observed, between 4 and 24 hpp, in kidneys overexpressing sod-2 but 
not in control kidneys (Figure 6, dark grey bars vs. black bars). Results also showed a 
significant negative effect in AcCMV_EGFP transduced kidney (Figure 6, light grey bars), 
with markedly reduced levels of intracellular ATP at 24 hpp compared to untreated 
AcCMV_SOD-2 transduced kidneys (Figure 6); these data were in line with results of the in 
vitro experiments (unpublished data). 
These observations are consistent with those made by Land et al.51 that sod exerts a 
beneficial effect against renal I/R injury through its antioxidant action. Furthermore, our study 
suggested a potential protective effect of ex vivo BacMam-mediated delivery of sod-2 
against long cold kidney preservation injury. However, there are clearly limitations inherent 
to the ex vivo cold perfusion model used in this experiment that need to be addressed in 
future studies. The main limitation is represented by the short lifespan of the organ perfused 
and knowing when valid data can be extracted during this time52. Ex vivo cold perfusion 
models are also restricted by the fact that hypothermic preservation can significantly 
decrease the organ’s metabolic functions, which can preclude full recovery53. 
In conclusion, the present findings confirm the feasibility of using BacMam as a gene 
delivery vector to prevent renal deterioration after tissue I/R injury in vitro as well as in ex 
vivo isolated perfused porcine kidney. In particular, this study showed the beneficial effect of 
BacMam-delivered sod-2, which protected kidney from further renal injury after ischemia. 
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Figure Legends 
Figure 1. MnSOD expression in HK-2 cells. BacMam virus containing MnSOD gene 
under control of the cytomegalovirus immediate early (CMV-IE) promoter, was used to 
transduce HK-2 cells at a multiplicity of infection (MOI) of 150. Transduced HK-2 cells 
were harvested at 0, 24, 48, 72 and 96 and cell lysates were western blotted onto 
nitrocellulose membrane using anti-MnSOD antibody. Lanes 0 to 96 represent time post-
transduction. The arrow refers to MnSOD proteins at approximately 23 kiloDalton (kDa). 
Figure 2. Time-course of ATP decay during simulated ischaemia in HK-2 cells. 
Control cells were incubated in KSF medium. HK-2 cells were exposed to antimycin A 
(10µM) and 2-Deoxy-D-Glucose (10 mM). ATP levels were determined every 15 min 
using a Cell TitreGlo assay (Promega). Error bars represent mean ± SEM (n=3) p<0.001 
indicated a significant difference between control and injured cells (two-way ANOVA). 
Figure 3. Intracellular ATP levels in I/R injured HK-2 cells. HK-2 cells were 
transduced with either AcCMV_NULL (filled squares) or AcCMV_MnSOD (filled 
triangles) at MOI 150. At 72 hpt transduced HK-2 cells were subjected to 60 min of 
simulated ischemia. Intracellular ATP levels were quantified over-time. Error bars 
represent mean ± SEM (n=3); *p<0.001 indicated a significant difference between control 
cells (non-injured) and AcCMV_MnSOD transduced injured cells. 
Figure 4. Effect of AcCMV_MnSOD on the release of lactate LDH from injured HK-2 
cells. Cells were transduced with either AcCMV_NULL (filled squares) or 
AcCMV_MnSOD (filled triangles) at MOI 150 for 72 h before being subjected to 60 min of 
simulated ischemia following reperfusion. AcCMV_MnSOD causes a time-dependent 
reduction of LDH release caused by antimycin A and 2-deoxyglucose. Data are 
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expressed as mean ± SEM (n=3); *p<0.001 indicated a significant difference between 
control cells (filled circles) and AcCMV_MnSOD transduced injured cells (filled triangles). 
Figure 5. Egfp expression in sections of control and BacMam transduced kidneys. 
Kidneys were incubated in BELZER UW® solution supplemented with or without 
AcCMV_EGFP virus and incubated at 4°C for 24 h. (A1) Control and (A2) BacMam 
transduced kidneys. The kidney sections were fixed with paraformaldehyde, 
immunofluorescent stained for egfp primary antibody and then labelled red with Alexa 
Fluor®-568 conjugated phalloidin secondary antibody. Tissues were analysed by 
confocal microscopy using an oil immersion x63 objective. Scale bar=10µm. 
Figure 6. Intracellular ATP levels in non-transduced and BacMam 
perfused/transduced porcine kidneys. Tissue kidney samples were collected over-
time from control groups (no virus; black bars), AcCMV_EGFP (light grey bars) and 
AcCMV_MnSOD (dark grey bars) transduced kidney groups. Kidney samples were 
enzymatically dissociated in single cells and ATP level measured over-time. Error bars 
represent mean ± SEM (n=3); *p<0.001 indicated a significant difference between the 
ATP levels of perfused control experimental group and AcCMV_MnSOD 
perfused/transduced kidneys. 
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